Cellular and molecular mechanisms of memory T-cell survival

Expert Review of Vaccines

Volumn 8, Issue 3, 2009, Pages 299-312

  Tanel, Andre ^a,b   Fonseca, Simone G ^a,b   Yassine Diab, Bader ^a,b   Bordi, Rebeka ^a,b   Zeidan, Joumana ^a,b   Shi, Yu ^a,b   Benne, Clarisse ^a,b   Sékaly, Rafick Pierre ^a,b,c,d  

^a CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

^c MCGILL UNIVERSITY   (Canada)

^d UNIVERSITY OF MONTREAL   (Canada)

Author keywords

Differentiation; FOXO3A; Memory; Signaling survival; T cell

Indexed keywords

VACCINE;

CELL SURVIVAL; CELLULAR IMMUNITY; HUMAN; INFECTION; INFECTION PREVENTION; LYMPHOCYTE ACTIVATION; LYMPHOCYTE PROLIFERATION; MEMORY T LYMPHOCYTE; NONHUMAN; PRIORITY JOURNAL; REVIEW; VACCINATION; VACCINE PRODUCTION; ANIMAL; CELL PROLIFERATION; IMMUNOLOGICAL MEMORY; IMMUNOLOGY; T LYMPHOCYTE; TIME;

ANIMALS; CELL PROLIFERATION; HUMANS; IMMUNOLOGIC MEMORY; T-LYMPHOCYTES; TIME FACTORS;

EID: 63849102086     PISSN: 14760584     EISSN: 17448395     Source Type: Journal    
DOI: 10.1586/14760584.8.3.299     Document Type: Review

References (142)

1. Dutton RW, Bradley LM, Swain SL. T cell memory. Annu. Rev. Immunol. 16, 201-223 (1998).
2. Combadiere B, Boissonnas A, Carcelain G et al. Distinct time effects of vaccination on long-term proliferative and IFN-γ-producing T cell memory to smallpox in humans. J. Exp. Med. 199(11), 1585-1593 (2004).
3. Courtois G. [Duration of immunity after yellow fever vaccination]. Ann. Soc. Belg. Med. Trop. (1920) 34(1), 9-12 (1954).
4. Poland JD, Calisher CH, Monath TP, Downs WG, Murphy K. Persistence of neutralizing antibody 30-35 years after immunization with 17D yellow fever vaccine. Bull. World Health Organ. 59(6), 895-900 (1981).
5. Sant AJ, Chaves FA, Krafcik FR et al. Immunodominance in CD4 T-cell responses: implications for immune responses to influenza virus and for vaccine design. Expert Rev. Vaccines 6(3), 357-368 (2007).
6. Wrammert J, Ahmed R. Maintenance of serological memory. Biol. Chem. 389(5), 537-539 (2008).
7. Sabbagh L, Kaech SM, Bourbonniere M et al. The selective increase in caspase-3 expression in effector but not memory T cells allows susceptibility to apoptosis. J. Immunol. 173(9), 5425-5433 (2004).
8. Diaz-Guerra E, Vernal R, del Prete MJ, Silva A, Garcia-Sanz JA. CCL2 inhibits the apoptosis program induced by growth factor deprivation, rescuing functional T cells. J. Immunol. 179(11), 7352-7357 (2007).
9. + T cell contraction. Immunity 28(2), 218-230 (2008).
10. + T cell differentiation: initial antigen encounter triggers a developmental program in naive cells. Nat. Immunol. 2(5), 415-422 (2001).
11. + T cell differentiation during viral infection. Immunity 27(3), 393-405 (2007).
12. Murali-Krishna K, Altman JD, Suresh M et al. Counting antigen-specific CD8 T cells: a reevaluation of bystander activation during viral infection. Immunity 8(2), 177-187 (1998).
13. Luckey CJ, Bhattacharya D, Goldrath AW, Weissman IL, Benoist C, Mathis D. Memory T and memory B cells share a transcriptional program of self-renewal with long-term hematopoietic stem cells. Proc. Natl Acad. Sci. USA 103(9), 3304-3309 (2006).
14. + central memory T cells. J. Exp. Med. 200(6), 725-735 (2004).
15. Murali-Krishna K, Lau LL, Sambhara S, Lemonnier F, Altman J, Ahmed R. Persistence of memory CD8 T cells in MHC class I-deficient mice. Science 286(5443), 1377-1381 (1999).
16. + T cells. J. Exp. Med. 195(12), 1515-1522 (2002).
17. Kaech SM, Tan JT, Wherry EJ, Konieczny BT, Surh CD, Ahmed R. Selective expression of the interleukin 7 receptor identifies effector CD8 T cells that give rise to long-lived memory cells. Nat. Immunol. 4(12), 1191-1198 (2003).
18. + regulatory T cells control Leishmania major persistence and immunity. Nature 420(6915), 502-507 (2002).
19. + T cells. J. Exp. Med. 195(12), 1533-1539 (2002).
20. Becker TC, Wherry EJ, Boone D et al. Interleukin 15 is required for proliferative renewal of virus-specific memory CD8 T cells. J. Exp. Med. 195(12), 1541-1548 (2002).
21. Schluns KS, Kieper WC, Jameson SC, Lefrancois L. Interleukin-7 mediates the homeostasis of naive and memory CD8 T cells in vivo. Nat. Immunol. 1(5), 426-432 (2000). • IL-7 and IL-15 are key cytokines in the survival of memory CD8 T cells.
22. King C, Ilic A, Koelsch K, Sarvetnick N. Homeostatic expansion of T cells during immune insufficiency generates autoimmunity. Cell 117(2), 265-277 (2004).
23. Barber DL, Wherry EJ, Ahmed R. Cutting edge: rapid in vivo killing by memory CD8 T cells. J. Immunol. 171(1), 27-31 (2003).
24. Wherry EJ, Teichgraber V, Becker TC et al. Lineage relationship and protective immunity of memory CD8 T cell subsets. Nat. Immunol. 4(3), 225-234 (2003).
25. Kersh EN, Fitzpatrick DR, Murali-Krishna K et al. Rapid demethylation of the IFN-γ gene occurs in memory but not naive CD8 T cells. J. Immunol. 176(7), 4083-4093 (2006).
26. Murphy KM, Reiner SL. The lineage decisions of helper T cells. Nat. Rev. Immunol. 2(12), 933-944 (2002).
27. + T lymphocytes. Proc. Natl Acad. Sci. USA 102(21), 7418-7425 (2005).
28. Sallusto F, Geginat J, Lanzavecchia A. Central memory and effector memory T cell subsets: function, generation, and maintenance. Annu. Rev. Immunol. 22, 745-763 (2004).
29. Sallusto F, Lenig D, Forster R, Lipp M, Lanzavecchia A. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 401(6754), 708-712 (1999).
30. Hazenberg MD, Otto SA, Hamann D et al. Depletion of naive CD4 T cells by CXCR4-using HIV-1 variants occurs mainly through increased T-cell death and activation. AIDS 17(10), 1419-1424 (2003).
31. Masopust D, Vezys V, Marzo AL, Lefrancois L. Preferential localization of effector memory cells in nonlymphoid tissue. Science 291(5512), 2413-2417 (2001).
32. Willinger T, Freeman T, Hasegawa H, McMichael AJ, Callan MF. Molecular signatures distinguish human central memory from effector memory CD8 T cell subsets. J. Immunol. 175(9), 5895-5903 (2005).
33. Bouneaud C, Garcia Z, Kourilsky P, Pannetier C. Lineage relationships, homeostasis, and recall capacities of central- and effector-memory CD8 T cells in vivo. J. Exp. Med. 201(4), 579-590 (2005).
34. Castiglioni P, Gerloni M, Zanetti M. Genetically programmed B lymphocytes are highly efficient in inducing anti-virus protective immunity mediated by central memory CD8 T cells. Vaccine 23(5), 699-708 (2004).
35. + T cells confer superior antitumor immunity compared with effector memory T cells. Proc. Natl Acad. Sci. USA 102(27), 9571-9576 (2005).
36. Wu CY, Kirman JR, Rotte MJ et al. Distinct lineages of Th1 cells have differential capacities for memory cell generation in vivo. Nat. Immunol. 3(9), 852-858 (2002).
37. Zaph C, Uzonna J, Beverley SM, Scott P. Central memory T cells mediate long-term immunity to Leishmania major in the absence of persistent parasites. Nat. Med. 10(10), 1104-1110 (2004).
38. + memory T-cell subsets in response to antigen or homeostatic cytokines. Blood 101(11), 4260-4266 (2003).
39. + T cell response by attenuated SIV infection. J. Exp. Med. 203(12), 2661-2672 (2006).
40. CM).
41. + T lymphocytes. J. Immunol. 178(7), 4112-4119 (2007).
42. Monteiro M, Evaristo C, Legrand A, Nicoletti A, Rocha B. Cartography of gene expression in CD8 single cells: novel CCR7-subsets suggest differentiation independent of CD45RA expression. Blood 109(7), 2863-2870 (2007).
43. + T cells. Trends Immunol. 24(8), 404-407 (2003).
44. + T cell effectors can become memory cells with high efficiency and without further division. Nat. Immunol. 2(8), 705-710 (2001).
45. Farber DL. Differential TCR signaling and the generation of memory T cells. J. Immunol. 160(2), 535-539 (1998).
46. Gett AV, Sallusto F, Lanzavecchia A, Geginat J. T cell fitness determined by signal strength. Nat. Immunol. 4(4), 355-360 (2003).
47. + central memory T cells into protective Listeria-specific effector memory T cells. Eur J. Immunol. 36(6), 1453-1464 (2006).
48. + effector memory T cells. J. Immunol. 175(3), 1433-1439 (2005).
49. CM cells. They proposed an asymmetric division model where effector and memory cells are formed simultaneously upon the first cell division of naive progenitor T cells.
50. Reiner SL, Sallusto F, Lanzavecchia A. Division of labor with a workforce of one: challenges in specifying effector and memory T cell fate. Science 317(5838), 622-625 (2007).
51. Stockinger B, Veldhoen M. Differentiation and function of Th17 T cells. Curr. Opin. Immunol. 19(3), 281-286 (2007).
52. + T cells. J. Exp. Med. 204(9), 2015-2021 (2007).
53. Rhyu MS, Jan LY, Jan YN. Asymmetric distribution of numb protein during division of the sensory organ precursor cell confers distinct fates to daughter cells. Cell 76(3), 477-491 (1994).
54. Lee CY, Andersen RO, Cabernard C et al. Drosophila Aurora-A kinase inhibits neuroblast self-renewal by regulating aPKC/Numb cortical polarity and spindle' orientation. Genes Dev. 20(24), 3464-3474 (2006).
55. Wang H, Somers GW, Bashirullah A, Heberlein U, Yu F, Chia W. Aurora-A acts as a tumor suppressor and regulates self-renewal of Drosophila neuroblasts. Genes Dev. 20(24), 3453-3463 (2006).
56. Chiba S. Notch signaling in stem cell systems. Stem Cells 24(11), 2437-2447 (2006).
57. Spana EP, Kopczynski C, Goodman CS, Doe CQ. Asymmetric localization of numb autonomously determines sibling neuron identity in the Drosophila CNS. Development 121(11), 3489-3494 (1995).
58. Anderson AC, Kitchens EA, Chan SW et al. The Notch regulator Numb links the Notch and TCR signaling pathways. J. Immunol. 174(2), 890-897 (2005).
59. Luty WH, Rodeberg D, Parness J, Vyas YM. Antiparallel segregation of notch components in the immunological synapse directs reciprocal signaling in allogeneic Th:DC conjugates. J. Immunol. 179(2), 819-829 (2007).
60. Kaech SM, Wherry EJ, Ahmed R. Effector and memory T-cell differentiation: implications for vaccine development. Nat. Rev. Immunol. 2(4), 251-262 (2002).
61. Sprent J, Cho JH, Boyman O, Surh CD. T cell homeostasis. Immunol. Cell. Biol. 86(4), 312-319 (2008).
62. + cells. J. Exp. Med. 195(12), 1523-1532 (2002).
63. Kondrack RM, Harbertson J, Tan JT, McBreen ME, Surh CD, Bradley LM. Interleukin 7 regulates the survival and generation of memory CD4 cells. J. Exp. Med. 198(12), 1797-1806 (2003).
64. Seddon B, Tomlinson P, Zamoyska R. Interleukin 7 and T cell receptor signals regulate homeostasis of CD4 memory cells. Nat. Immunol. 4(7), 680-686 (2003).
65. Swain SL, Hu H, Huston G. Class II-independent generation of CD4 memory T cells from effectors. Science 286(5443), 1381-1383 (1999).
66. Zamoyska R, Basson A, Filby A, Legname G, Lovatt M, Seddon B. The influence of the src-family kinases, Lck and Fyn, on T cell differentiation, survival and activation. Immunol. Rev. 191, 107-118 (2003).
67. Kassiotis G, Garcia S, Simpson E, Stockinger B. Impairment of immunological memory in the absence of MHC despite survival of memory T cells. Nat. Immunol. 3(3), 244-250 (2002).
68. Curtsinger JM, Johnson CM, Mescher MF. CD8 T cell clonal expansion and development of effector function require prolonged exposure to antigen, costimulation, and signal 3 cytokine. J. Immunol. 171(10), 5165-5171 (2003).
69. Chan AC, Iwashima M, Turck CW, Weiss A. ZAP-70: a 70 kd protein-tyrosine kinase that associates with the TCRCζ chain. Cell 71(4), 649-662 (1992).
70. Bubeck Wardenburg J, Fu C, Jackman JK et al. Phosphorylation of SLP-76 by the ZAP-70 protein-tyrosine kinase is required for T-cell receptor function. J Biol. Chem. 271(33), 19641-19644 (1996).
71. Zhang W, Sloan-Lancaster J, Kitchen J, Trible RP, Samelson LE. LAT: the ZAP-70 tyrosine kinase substrate that links T cell receptor to cellular activation. Cell 92(1), 83-92 (1998).
72. Jordan MS, Singer AL, Koretzky GA. Adaptors as central mediators of signal transduction in immune cells. Nat. Immunol. 4(2), 110-116 (2003).
73. Kuo CT, Leiden JM. Transcriptional regulation of T lymphocyte development and function. Annu. Rev. Immunol. 17, 149-187 (1999).
74. Krishnan S, Warke VG, Nambiar MP, Tsokos GC, Farber DL. The FcR γ subunit and Syk kinase replace the CD3ζ-chain and ZAP-70 kinase in the TCR signaling complex of human effector CD4 T cells. J. Immunol. 170(8), 4189-4195 (2003).
75. Krishnan S, Warke VG, Nambiar MP, Wong HK, Tsokos GC, Farber DL. Generation and biochemical analysis of human effector CD4 T cells: alterations in tyrosine phosphorylation and loss of CD3ζ, expression. Blood 97(12), 3851-3859 (2001).
76. Hussain SF, Anderson CF, Farber DL. Differential SLP-76 expression and TCR-mediated signaling in effector and memory CD4 T cells. J. Immunol. 168(4), 1557-1565 (2002). • Memory cells have lower levels of tyrosine phosphorylation than effector cells.
77. Farber DL, Acuto O, Bottomly K. Differential T cell receptor-mediated signaling in naive and memory CD4 T cells. Eur J. Immunol. 27(8), 2094-2101 (1997).
78. Ahmadzadeh M, Hussain SF, Farber DL. Effector CD4 T cells are biochemically distinct from the memory subset: evidence for long-term persistence of effectors in vivo. J. Immunol. 163(6), 3053-3063 (1999).
79. CM cells from elite controller subjects is a direct consequence of the inactivation of the FOXO3a pathway.
80. Yang JY, Zong CS, Xia W et al. ERK promotes tumorigenesis by inhibiting FOXO3a via MDM2-mediated degradation. Nat. Cell Biol. 10(2), 138-148 (2008).
81. Khaled AR, Durum SK. Lymphocide: cytokines and the control of lymphoid homeostasis. Nat. Rev. Immunol. 2(11), 817-830 (2002).
82. + T lymphocyte proliferation. J. Immunol. 176(4), 2173-2182 (2006).
83. Schluns KS, Williams K, Ma A, Zheng XX, Lefrancois L. Cutting edge: requirement for IL-15 in the generation of primary and memory antigen-specific CD8 T cells. J. Immunol. 168(10), 4827-4831 (2002). • IL-7 and IL-15 are key cytokines in the survival of memory CD8 T cells.
84. + T cells and NK cells in simian immunodeficiency virus-infected macaques. J. Virol. 79(8), 4877-4885 (2005).
85. + memory T cells are IL-15 dependent. J. Exp. Med. 204(4), 951-961 (2007). • IL-7 and IL-15 are key cytokines in the survival of memory CD8 T cells.
86. Akashi K, Kondo M, von Freeden-Jeffry U, Murray R, Weissman IL. Bcl-2 rescues T lymphopoiesis in interleukin-7 receptor-deficient mice. Cell 89(7), 1033-1041 (1997).
87. Blattman JN, Grayson JM, Wherry EJ, Kaech SM, Smith KA, Ahmed R. Therapeutic use of IL-2 to enhance antiviral T-cell responses in vivo. Nat. Med. 9(5), 540-547 (2003).
88. Kaech SM, Hemby S, Kersh E, Ahmed R. Molecular and functional profiling of memory CD8 T cell differentiation. Cell 111(6), 837-851 (2002).
89. + T cells. J. Immunol. 164(8), 3950-3954 (2000).
90. Allen SJ, Crown SE, Handel TM. Chemokine: receptor structure, interactions, and antagonism. Annu. Rev. Immunol. 25, 787-820 (2007).
91. + T cell response to respiratory virus infections. Immunity 29(1), 101-113 (2008).
92. Oppermann M. Chemokine receptor CCR5: insights into structure, function, and regulation. Cell. Signal. 16(11), 1201-1210 (2004).
93. Sanchez-Sanchez N, Riol-Blanco L, de la Rosa G et al. Chemokine receptor CCR7 induces intracellular signaling that inhibits apoptosis of mature dendritic cells. Blood 104(3), 619-625 (2004).
94. Ziegler E, Oberbarnscheidt M, Bulfone-Paus S, Forster R, Kunzendorf U, Krautwald S. CCR7 signaling inhibits T cell proliferation. J. Immunol. 179(10), 6485-6493 (2007).
95. Ticchioni M, Essafi M, Jeandel PY et al. Homeostatic chemokines increase survival of B-chronic lymphocytic leukemia cells through inactivation of transcription factor FOXO3a. Oncogene 26(50), 7081-7091 (2007).
96. Walsh PT, Smith LM, O'Connor R. Insulin-like growth factor-1 activates Akt and Jun N-terminal kinases (JNKs) in promoting the survival of T lymphocytes. Immunology 107(4), 461-471 (2002).
97. Congote LF. Monitoring insulin-like growth factors in HIV infection and AIDS. Clin. Chim. Acta 361(1-2), 30-53 (2005).
98. + effector memory T cells are precursors of bystander-activated effectors: a surrogate model of rheumatoid arthritis synovial T-cell function. Arthritis Res. Ther. 10(2), R36 (2008).
99. Danielpour D, Song K. Cross-talk between IGF-I and TGF-β signaling pathways. Cytokine Growth Factor Rev. 17(1-2), 59-74 (2006).
100. + regulatory T cells. J. Exp. Med. 201(7), 1061-1067 (2005).
101. Alard P, Clark SL, Kosiewicz MM. Mechanisms of tolerance induced by TGF β-treated APC: CD4 regulatory T cells prevent the induction of the immune response possibly through a mechanism involving TGF β. Eur J. Immunol. 34(4), 1021-1030 (2004).
102. + regulatory T cell activity in both humans and mice. J. Immunol. 172(2), 834-842 (2004).
103. Li MO, Wan YY, Sanjabi S, Robertson AK, Flavell RA. Transforming growth factor-β regulation of immune responses. Annu. Rev. Immunol. 24, 99-146 (2006).
104. Das L, Levine AD. TGF-β inhibits IL-2 production and promotes cell cycle arrest in TCR-activated effector/memory T cells in the presence of sustained TCR signal transduction. J. Immunol. 180(3), 1490-1498 (2008).
105. Sudarshan C, Galon J, Zhou Y, O'Shea JJ. TGF-β does not inhibit IL-12- and IL-2-induced activation of Janus kinases and STATs. J. Immunol. 162(5), 2974-2981 (1999).
106. + progenitors through FoxO3 and mTOR. Stem Cells 26(12), 3150-3161 (2008).
107. Giachelli CM, Lombardi D, Johnson RJ, Murry CE, Almeida M. Evidence for a role of osteopontin in macrophage infiltration in response to pathological stimuli in vivo. Am. J. Pathol. 152(2), 353-358 (1998).
108. Ashkar S, Weber GF, Panoutsakopoulou V et al. Eta-1 (osteopontin): an early component of type-1 (cell-mediated) immunity. Science 287(5454), 860-864 (2000).
109. Hur EM, Youssef S, Haws ME, Zhang SY, Sobel RA, Steinman L. Osteopontin-induced relapse and progression of autoimmune brain disease through enhanced survival of activated T cells. Nat. Immunol. 8(1), 74-83 (2007).
110. Shin H, Wherry EJ. CD8 T cell dysfunction during chronic viral infection. Curr. Opin. Immunol. 19(4), 408-415 (2007).
111. Ha SJ, West EE, Araki K, Smith KA, Ahmed R. Manipulating both the inhibitory and stimulatory immune system towards the success of therapeutic vaccination against chronic viral infections. Immunol. Rev. 223, 317-333 (2008). • Programmed death (PD)-1 is a regulator of T-cell survival in HIV infection.
112. + T cell exhaustion by multiple inhibitory receptors during chronic viral infection. Nat. Immunol. 10(1), 29-37 (2009). • PD-1 is a regulator of T-cell survival in HIV infection.
113. + T cells leads to reversible immune dysfunction. Nat. Med. 12(10), 1198-1202 (2006). • PD-1 is a regulator of T-cell survival in HIV infection.
114. Brenchley JM, Price DA, Schacker TW et al. Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat. Med. 12(12), 1365-1371 (2006). • PD-1 is a regulator of T-cell survival in HIV infection.
115. + T cell survival in HIV infection. J. Exp. Med. 203(10), 2281-2292 (2006). • PD-1 is a regulator of T-cell survival in HIV infection.
116. + memory T cells. J. Virol. 82(20), 10017-10031 (2008).
117. Esser MT, Marchese RD, Kierstead LS et al. Memory T cells and vaccines. Vaccine 21(5-6), 419-430 (2003).
118. Fruman DA. Phosphoinositide 3-kinase and its targets in B-cell and T-cell signaling. Curr. Opin. Immunol. 16(3), 314-320 (2004).
119. Staal FJ, Luis TC, Tiemessen MM. WNT signalling in the immune system: WNT is spreading its wings. Nat. Rev. Immunol. 8(8), 581-593 (2008).
120. Wang C, Wen T, Routy JP, Bernard NF, Sekaly RP, Watts TH. 4-1BBL induces TNF receptor-associated factor 1-dependent Bim modulation in human T cells and is a critical component in the costimulation-dependent rescue of functionally impaired HIV-specific CD8 T cells. J. Immunol. 179(12), 8252-8263 (2007).
121. + T cells correlates with disease progression and defines a reversible immune dysfunction. Nat. Immunol. 8(11), 1246-1254 (2007).
122. + TCR αβ and TCR γδ CTL in vivo. Immunol. Rev. 146, 82-94 (1995).
123. + T cells. J. Exp. Med. 186(9), 1407-1418 (1997).
124. Lanzavecchia A, Sallusto F. Understanding the generation and function of memory T cell subsets. Curr. Opin. Immunol. 17(3), 326-332 (2005).
125. + T cells. J. Exp. Med. 194(12), 1711-1719 (2001).
126. high "memory phenotype" CD8 T cells: comparison between memory CD8 T cells and thymus-independent CD8 T cells. Eur. J. Immunol. 31(6), 1917-1926 (2001).
127. Tough DF, Sun S, Zhang X, Sprent J. Stimulation of naive and memory T cells by cytokines. Immunol. Rev. 170, 39-47 (1999).
128. Cohavy O, Targan SR. CD56 marks an effector T cell subset in the human intestine. J. Immunol. 178(9), 5524-5532 (2007).
129. + T cells closely correlates with CD56 surface expression. J. Immunol. 164(3), 1148-1152 (2000).
130. + T cells in aged humans. Exp. Gerontol. 43(4), 266-274 (2008).
131. Cannons JL, Lau P, Ghumman B et al. 4-1BB ligand induces cell division, sustains survival, and enhances effector function of CD4 and CD8 T cells with similar efficacy. J. Immunol. 167(3), 1313-1324 (2001).
132. Mackey MF, Barth RJ Jr, Noelle RJ. The role of CD40/CD154 interactions in the priming, differentiation, and effector function of helper and cytotoxic T cells. J. Leukoc. Biol. 63(4), 418-428 (1998).
133. Ishii T, Ohnuma K, Murakami A et al. CD26-mediated signaling for T cell activation occurs in lipid rafts through its association with CD45RO. Proc. Natl Acad. Sci. USA 98(21), 12138-12143 (2001).
134. + T cells can be distinguished by their cytokine profiles and phenotypic markers. J. Immunol. 164(1), 208-216 (2000).
135. Holse M, Assing K, Poulsen LK. CCR3, CCR5, CCR8 and CXCR3 expression in memory T helper cells from allergic rhinitis patients, asymptomatically sensitized and healthy individuals. Clin. Mol. Allergy 4, 6 (2006).
136. Nicholson JK, Browning SW, Hengel RL et al. CCR5 and CXCR4 expression on memory and naive T cells in HIV-1 infection and response to highly active antiretroviral therapy. J. Acquir. Immune Defic. Syndr. 27(2), 105-115 (2001).
137. + T cells. J. Immunol. 168(5), 2225-2232 (2002).
138. + T-cells migrating into the cerebrospinal fluid of patients with neuroborreliosis: the role of CXCL10 and CXCL11. J. Neuroimmunol. 163(1-2), 128-134 (2005).
139. Hutloff A, Dittrich AM, Beier KC et al. ICOS is an inducible T-cell co-stimulator structurally and functionally related to CD28. Nature397(6716), 263-266 (1999).
140. Sharpe AH, Wherry EJ, Ahmed R, Freeman GJ. The function of programmed cell death 1 and its ligands in regulating autoimmunity and infection. Nat. Immunol. 8(3), 239-245 (2007).
141. + T cells from naive cells. J. Immunol. 161(2), 641-648 (1998).
142. Harrington LE, Galvan M, Baum LG, Altman JD, Ahmed R. Differentiating between memory and effector CD8 T cells by altered expression of cell surface O-glycans. J. Exp. Med. 191(7), 1241-1246 (2000).